| 1. |
Stender MT, Larsen AC, Sall M, et al. D-dimer predicts prognosis and non-resectability in patients with pancreatic cancer: a prospective cohort study. Blood Coagul Fibrinolysis, 2016, 27(5): 597-601.
|
| 2. |
張成大, 何君, 黃婷, 等. 結直腸癌患者血清CEA和D-二聚體檢測臨床意義. 中華腫瘤防治雜志, 2018, 25(4): 282-286.
|
| 3. |
Phan TT, Ho TT, Nguyen HT, et al. The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small cell lung cancer patients treated with EGFR TKI. Int J Gen Med, 2018, 11: 423-430.
|
| 4. |
Zhou D, Wu Y, Lin Z, et al. Prognostic value of combination of pretreatment red cell distribution width and neutrophil-to-lymphocyte ratio in patients with gastric cancer. Gastroenterol Res Pract, 2018, 2018: 8042838. doi: 10.1155/2018/8042838.
|
| 5. |
Yang C, Cheng H, Luo G, et al. The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: a new scoring system. Eur J Surg Oncol, 2017, 43(11): 2112-2118.
|
| 6. |
Baert T, Van Camp J, Vanbrabant L, et al. Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients. Gynecol Oncol, 2018, 150(1): 31-37.
|
| 7. |
Mubarak AI, Morani AC, Samuel J, et al. Can presurgical ultrasound predict survival in women with ovarian masses? Ultrasound Q, 2019, 35(1): 39-44.
|
| 8. |
Zhang W, Liu X, Cheng H, et al. Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China. Medicine (Baltimore), 2018, 97(31): e11754. doi: 10.1097/MD.0000000000011754.
|
| 9. |
Fül?p ZZ, Gurzu S, Fül?p RL, et al. Prognostic impact of the neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratio, in patients with rectal cancer: a retrospective study of 1 052 patients. J Pers Med, 2020, 10(4): 173. doi: 10.3390/jpm10040173.
|
| 10. |
申鵬, 張太平. 術前NLR、PLR對胰腺癌患者術后1年生存率的預測價值. 北京: 北京協和醫學院, 2016.
|
| 11. |
易福梅, 顧陽春, 陳森, 等. 治療前后NLR和PLR對進展期非小細胞肺癌一線化療療效及預后的預測價值. 中國肺癌雜志, 2018, 21(6): 481-492.
|
| 12. |
Miyamoto R, Inagawa S, Sano N, et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol, 2018, 44(5): 607-612.
|
| 13. |
Beal EW, Wei L, Ethun CG, et al. Elevated NLR in gallbladder cancer and cholangiocarcinoma—making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium. HPB (Oxford), 2016, 18(11): 950-957.
|
| 14. |
Yang Z, Gu JH, Guo CS, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies. Oncotarget, 2017, 8(28): 46414-46424.
|
| 15. |
Khatib G, Soysal C, ?etin C, et al. Does preoperative neutrophil to lymphocyte or platelet to lymphocyte ratios have a role in predicting borderline ovarian tumors?. J Ovarian Res, 2016, 9(1): 78. doi: 10.1186/s13048-016-0283-2.
|
| 16. |
Xiang J, Zhou L, Li X, et al. Preoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancer. Transl Oncol, 2017, 10(1): 33-39.
|
| 17. |
Nanki Y, Chiyoda T, Kataoka F, et al. Elevated preoperative neutrophil: lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation. J Obstet Gynaecol Res, 2017, 43(4): 744-748.
|
| 18. |
Wu J, Fu Z, Liu G, et al. Clinical significance of plasma D-dimer in ovarian cancer: a meta-analysis. Medicine (Baltimore), 2017, 96(25): e7062. doi: 10.1097/MD.0000000000007062.
|
| 19. |
Yildiz Y, Kucukzeybek Y, Alacacioglu A, et al. Prognostic value of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with epithelial ovarian cancer. Eur J Gynaecol Oncol, 2017, 38(3): 444-448.
|
| 20. |
李恒妍, 鄺土光, 龔娟妮, 等. 血漿D-二聚體及血清腫瘤標志物在特發性肺栓塞并肺腺癌診斷中的價值. 中華實用診斷與治療雜志, 2018, 32(9): 870-873.
|
| 21. |
Liang Y, He D, Wu L, et al. Elevated preoperative plasma D-dimer dose not adversely affect survival of gastric cancer after gastrectomy with curative intent: a propensity score analysis. Chin J Cancer Res, 2018, 30(2): 254-262.
|
| 22. |
Liu L, Zhang X, Yan B, et al. Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients. PLoS One, 2014, 9(3): e90547. doi: 10.1371/journal.pone.0090547.
|
| 23. |
石慧, 胡建國. HE4、CA125聯合D-二聚體檢測對卵巢癌的診斷價值. 蚌埠醫學院學報, 2020, 45(4): 523-526.
|
| 24. |
李達, 何靜. 婦科惡性腫瘤患者凝血功能及D-二聚體水平變化及意義. 中華實用診斷與治療雜志, 2016, 30(6): 596-597.
|
| 25. |
黃利軍, 方佳峰, 吳玨堃, 等. 術前血清腫瘤標志物聯合血常規指標對結直腸癌患者預后評估的價值. 中華胃腸外科雜志, 2018, 21(12): 1421-1426.
|